Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review
- PMID: 33990972
- PMCID: PMC8242919
- DOI: 10.1002/jmv.27081
Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review
Abstract
The human immune system is not adequately equipped to eliminate new microbes and could result in serious damage on first exposure. This is primarily attributed to the exaggerated immune response (inflammatory disease), which may prove detrimental to the host, as evidenced by SARS-CoV-2 infection. From the experiences of Novel Coronavirus Disease-19 to date, male patients are likely to suffer from high-intensity inflammation and disease severity than the female population. Hormones are considered the significant pillars of sex differences responsible for the discrepancy in immune response exhibited by males and females. Females appear to be better equipped to counter invading respiratory viral pathogens, including the novel SARS-CoV-2, than males. It can be hypothesized that females are more shielded from disease severity, probably owing to the diverse action/influence of estrogen and other sex hormones on both cellular (thymus-derived T lymphocytes) and humoral immunity (antibodies).
Keywords: COVID-19; SARS-CoV-2; estrogen; gender biasness; immune system; inflammation; sex hormones.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J. 2006;25:680‐686. - PubMed
-
- Mohapatra RK, Perekhoda L, Azam M, et al. Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS‐CoV‐2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis. J. King Saud Univ.–Sci. 2021;33:101315. - PMC - PubMed
-
- Mohapatra RK, Das PK, Pintilie L, Dhama K. Infection capability of SARS‐CoV‐2 on different surfaces. Egypt J Basic Appl Sci. 2021;8(1):75‐80.
-
- Arumugam VA, Thangavelu S, Fathah Z, et al. COVID‐19 and the world with co‐morbidities of heart disease, hypertension and diabetes. J Pure Appl Microbiol. 2020;14(3):1623‐1638.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
